🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the antibody neutralization activity and safety of rabies mAb C...
Status
Unknown
Location
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Start Date
2024-07-31
Trial ID
NCT06548139
A Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial t...
Status
Not Yet Recruiting
Location
Lanzhou Institute of Biological Products Co., Ltd.
Start Date
2026-01-31
Trial ID
NCT07445815
The aim of this study is to evaluate the safety of the monoclonal antibody ...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2008-05
Trial ID
NCT00708084
This multicenter, observer-blind, controlled, randomized, Phase II study wa...
Status
Completed
Location
Investigational Site
Start Date
2017-04-17
Trial ID
NCT03145766
Treatments Being Tested
This study is a randomized, double-blind, active-controlled design. The goa...
Status
Completed
Location
Yuping Dong Autonomous County Center for Disease Control and Prevention
Start Date
2024-11-30
Trial ID
NCT07342257
Treatments Being Tested
Demonstrate non-inferiority of the immune response between new versus the c...
Status
Completed
Location
4, De La Salle Health Sciences Institute
Start Date
2014-06
Trial ID
NCT02177032
Primary Objective: To describe the immune response induced by VRVg-2 and V...
Status
Completed
Location
Investigational Site Number :7640004
Start Date
2020-08-04
Trial ID
NCT04478084